Workflow
Axon(AXON)
icon
Search documents
Axon Cuts Losses After Diving On Q3 Miss, Promises 'Really Big' Q4
Investors· 2025-11-05 19:26
Group 1 - Axon Enterprise reported third-quarter earnings per share that fell short of analyst estimates due to margin impacts from tariffs and investments in new products [1] - Despite the earnings miss, Axon indicated that Q4 is expected to be significant for bookings, suggesting potential recovery [1] - Axon stock was among the top losers in the S&P 500 following the earnings report, reflecting market reaction to the disappointing results [1] Group 2 - Axon has been recognized for its expanding product line, which is driving strong profit and sales growth, indicating a positive long-term outlook [3] - The stock has recently achieved a record high and secured a position on multiple best growth stock lists, showcasing its strong market performance [3] - Analysts have noted improving technical performance for Axon, suggesting potential for continued strength in the stock [3]
Axon's Q3 Earnings Miss Estimates & Revenues Beat, 2025 View Up
ZACKS· 2025-11-05 18:46
Core Insights - Axon Enterprise, Inc. reported third-quarter 2025 adjusted earnings of $1.17 per share, missing the Zacks Consensus Estimate of $1.63, with a year-over-year decrease of 19.3% due to rising operating costs and expenses [1][6] Revenue Performance - Total revenues reached $710.6 million, exceeding the consensus estimate of $700 million, and reflecting a 31% year-over-year increase driven by strong demand for TASER 10, Axon Body 4, and counter-drone equipment, along with growing adoption of premium software solutions [2] Business Segment Performance - **Connected Devices**: Revenues increased by 23.6% year over year to $405.4 million, driven by demand for TASER 10 devices and Axon Body 4, although adjusted gross margin decreased to 52.1% from 54.5% [4] - **Software & Services**: Revenues surged 41.1% year over year to $305.2 million, supported by an increase in users and premium software adoption, with adjusted gross margin improving to 76.8% from 76.3% [5] Margin Profile - Cost of sales rose 32.7% year over year to $283.3 million, while total operating expenses climbed 40% to $429.5 million, leading to a decrease in adjusted gross margin to 62.7% from 63.2% [6] Balance Sheet & Cash Flow - At the end of Q3 2025, cash and cash equivalents stood at $1.42 billion, a significant increase from $454.8 million at the end of 2024. However, net cash used from operating activities was $5.9 million compared to $158.1 million generated in the previous year [7] - Adjusted free cash flow was negative $71.4 million in the first nine months of 2025, down from $117.5 million in the prior-year period [8] Outlook - For Q4 2025, Axon anticipates revenues between $750 million and $755 million, indicating a 31% increase at the midpoint, with projected adjusted EBITDA of $178-$182 million [9] - For the full year 2025, revenues are expected to be around $2.74 billion, reflecting approximately 31% year-over-year growth, with an adjusted EBITDA margin of about 25% [11] Major Developments - Axon signed a definitive agreement to acquire Carbyne for $625 million, expected to close in Q1 2026, pending customary closing conditions [13]
Why Axon Enterprise Stock Is Plummeting Today
Yahoo Finance· 2025-11-05 17:02
Core Viewpoint - Axon Enterprise's stock experienced a significant decline following its Q3 earnings report, with a notable drop of 12.1% during trading, and a peak decline of 20.7% at market open, primarily due to earnings missing analyst expectations despite revenue exceeding forecasts [1][3]. Financial Performance - Axon reported non-GAAP adjusted earnings per share of $1.17 on revenue of $710.64 million, surpassing Wall Street's revenue target by approximately $5.8 million, but falling short of earnings expectations by $0.37 [3]. - The company achieved a year-over-year revenue growth of 30.6% in Q3, although weaker-than-expected margins have led to a sell-off in the stock [3][6]. Future Guidance - For Q4, Axon is projecting revenue between $750 million and $755 million, which would lead to an estimated full-year revenue of approximately $2.74 billion, exceeding the average Wall Street analyst target of $2.72 billion [4]. - However, the guidance for adjusted EBITDA between $178 million and $182 million has not met investor expectations, contributing to the stock's decline [4]. Acquisition Announcement - Axon announced its intention to acquire Carbyne, a public-safety technology specialist, for $625 million, with the deal expected to close in the first quarter of the following year [5].
TASER maker Axon plunges 17% after earnings fall short due to tariff hit
CNBC· 2025-11-05 14:49
Core Insights - Axon Enterprise's stock dropped 17% after missing third-quarter profit expectations due to tariff constraints [1] - Adjusted earnings were $1.17 per share, below the forecast of $1.52 per share [1] - Adjusted gross margins decreased by 50 basis points year-over-year to 62.7%, attributed to tariff impacts [1] Financial Performance - The connected devices business, including TASER and counter-drone equipment, generated over $405 million in revenues, a 24% year-over-year increase [2] - Software and services revenues rose 41% year-over-year to $305 million [2] Management Commentary - The finance chief indicated that the tariff impacts are considered a one-time adjustment and are now reflected in gross margins [2] - There is an expectation that growth in the software business will eventually offset margin losses in the long term [2]
Axon Enterprise Stock: Why I'm Catching This Falling Knife
Seeking Alpha· 2025-11-05 14:33
Core Points - The author has a background in finance and computer science, with ten years of experience writing for Seeking Alpha [1] - The author emphasizes the importance of community engagement and diverse opinions within the Seeking Alpha platform [1] Group 1 - The author has passed all three levels of the CFA exam and currently works in fintech as a data engineer [1] - The author encourages readers to engage with their articles and share thoughts, highlighting the value of community feedback [1] Group 2 - The articles and comments made by the author are not considered financial or investment advice, but rather personal opinions [2] - The author has no current stock or derivative positions in the companies mentioned but may consider initiating a short position in AXON within the next 72 hours [1]
Axon Enterprise Stock: Why I'm Catching This Falling Knife (NASDAQ:AXON)
Seeking Alpha· 2025-11-05 14:33
To follow me click the "Follow" button! (Easy right?) Hi there, thanks for coming to my profile page! My name is Kumquat Research (but you can call me Jeremy) and I've been writing for Seeking Alpha on and off for going on ten years now, beginning with my inaugural published piece during my first year of college. I have a double degree in finance and computer science, have passed all three levels of the CFA exam, and currently work in fintech as a data engineer. Finding the time to write becomes more diffic ...
Super Micro Computer Posts Downbeat Q1 Results, Joins Pinterest, Axon Enterprise And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga· 2025-11-05 13:45
Core Points - U.S. stock futures are lower, with Dow futures falling over 50 points [1] - Super Micro Computer Inc reported disappointing first-quarter results, with earnings of 35 cents per share, missing the consensus estimate of 40 cents, and revenue of $5.01 billion, below the expected $5.99 billion [2] - Super Micro's revenue decreased from $5.93 billion in the same period last year [2] - The company's shares fell 9.2% to $43.12 in pre-market trading [2] Company-Specific Movements - Biohaven Ltd experienced a significant drop of 46.2% to $7.51 after receiving an FDA Complete Response Letter for VYGLXIA [4] - Trex Company Inc declined 31.9% to $32.02 following worse-than-expected third-quarter results and lowered FY25 sales guidance [4] - Soleno Therapeutics Inc fell 22.2% to $49.65 after reporting third-quarter results [4] - Axon Enterprise Inc's shares dropped 19.6% to $567.50 after mixed third-quarter results and an acquisition announcement [4] - Pinterest Inc dipped 18.8% to $26.69 after posting disappointing third-quarter earnings [4] - SSR Mining Inc fell 17.5% to $17.90 after its third-quarter results [4] - Uniqure NV's shares decreased by 15.8% to $25.61 after a prior gain [4] - Clover Health Investments Corp fell 15.5% to $2.97 after mixed third-quarter results [4] - Upstart Holdings Inc declined 15.3% to $39.15 after mixed results and lowered FY25 guidance [4] - Corsair Gaming Inc fell 12.4% to $6.59 following worse-than-expected third-quarter results [4] - Advanced Micro Devices, Inc. declined 5% to $237.80 despite reporting better-than-expected third-quarter results and projecting fourth-quarter revenue of approximately $9.6 billion [4]
Axon shares extend fall as tariffs hurt the Taser maker's quarterly profit
Reuters· 2025-11-05 13:27
Core Insights - Axon Enterprise's shares fell by 19% in premarket trading following a disappointing third-quarter profit report that missed analysts' expectations due to increased costs from U.S. tariffs [1] Company Summary - The decline in Axon Enterprise's stock price reflects investor reaction to the company's financial performance, specifically the impact of higher costs attributed to tariffs [1]
Morning Market Movers: SMX, BHVN, TREX, EVC See Big Swings
RTTNews· 2025-11-05 12:24
Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - SMX (Security Matters) Public Limited Company (SMX) increased by 52% to $2.24 [3] - Entravision Communications Corporation (EVC) rose by 33% to $2.66 [3] - Babcock & Wilcox Enterprises, Inc. (BW) saw a 28% increase to $4.79 [3] - NeuroPace, Inc. (NPCE) gained 24% reaching $11.71 [3] - Kennedy-Wilson Holdings, Inc. (KW) also increased by 24% to $9.30 [3] - Rigel Pharmaceuticals, Inc. (RIGL) rose by 22% to $34.72 [3] - Digital Turbine, Inc. (APPS) increased by 21% to $7.20 [3] - Lumentum Holdings Inc. (LITE) saw a 15% increase to $218.06 [3] - AsiaStrategy (SORA) rose by 14% to $3.63 [3] - Marine Petroleum Trust (MARPS) increased by 7% to $5.05 [3] Premarket Losers - Biohaven Ltd. (BHVN) decreased by 42% to $7.96 [4] - Trex Company, Inc. (TREX) fell by 34% to $30.65 [4] - Soleno Therapeutics, Inc. (SLNO) saw a 23% decline to $49.00 [4] - Axon Enterprise, Inc. (AXON) decreased by 19% to $572.00 [4] - Clover Health Investments, Corp. (CLOV) fell by 19% to $2.82 [4] - Pinterest, Inc. (PINS) decreased by 18% to $26.91 [4] - SSR Mining Inc. (SSRM) saw a 17% decline to $17.91 [4] - Upstart Holdings, Inc. (UPST) decreased by 16% to $38.81 [4] - WF International Limited (WXM) fell by 12% to $2.25 [4] - Corsair Gaming, Inc. (CRSR) decreased by 11% to $6.66 [4]
Axon Enterprise, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:AXON) 2025-11-05
Seeking Alpha· 2025-11-05 10:03
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...